trapidil has been researched along with Abdominal Aortic Aneurysm in 1 studies
Trapidil: A coronary vasodilator agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagashima, H | 1 |
| Aoka, Y | 1 |
| Sakomura, Y | 1 |
| Uto, K | 1 |
| Sakuta, A | 1 |
| Aomi, S | 1 |
| Kurosawa, H | 1 |
| Hagiwara, N | 1 |
| Kawana, M | 1 |
| Kasanuki, H | 1 |
1 other study available for trapidil and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall.
Topics: Aortic Aneurysm, Abdominal; Case-Control Studies; CD40 Antigens; CD40 Ligand; Humans; Immunohistoche | 2004 |